Foster Rx renders evidence-grade diligence across the lifecycle of pharmaceutical and biotechnology assets. Four audience seats over one provenance-attributed substrate. Pick the one that matches your seat at the table.
Diligence on other people's programs. Investment committee, venture partner, family office, corporate development, life-sciences M&A.
In-licensing diligence, partnership evaluation, pharma BD. Evaluating programs for advancement, acquisition, or co-development.
Translational research, spin-out evaluation, academic deal architecture, commercialization scoring across the disclosure portfolio.
Click a role to open the matching scorecard.
